High degree of resistance to antibiotics in Arctic birdsJanuary 14, 2008In the latest issue of the journal Emerging Infectious Diseases, Swedish researchers report that birds captured in the hyperboreal tundra, in connection with the tundra expedition "Beringia 2005," were carriers of antibiotics-resistant bacteria. These findings indicate that resistance to antibiotics has spread into nature, which is an alarming prospect for future health care. The scientists took samples from 97 birds in northeastern Siberia, northern Alaska, and northern Greenland. These samples were cultivated directly in special laboratories that the researchers had installed onboard the icebreaker Oden and were further analyzed at the microbiological laboratory at the Central Hospital in Växjö, Sweden. "We were extremely surprised," says Björn Olsen, professor of infectious diseases at Uppsala University and at the Laboratory for Zoonosis Research at the University of Kalmar. "We took samples from birds living far out on the tundra and had no contact with people. This further confirms that resistance to antibiotics has become a global phenomenon and that virtually no region of the earth, with the possible exception of the Antarctic, is unaffected." The researchers' hypothesis is that immigrating birds have passed through regions in Southeast Asia, for example, where there is a great deal of antibiotics pressure and carried with them the resistant bacteria to the tundra. "We already knew that birds in the Western world can be carriers of bacteria that are resistant to antibiotics, but it's alarming to find that these bacteria exist among birds out on the tundra," says Jonas Bonnedahl, a physician infectious specializing in infectious diseases in Kalmar and one of those participating in the expedition. "Our findings show that resistance to antibiotics is not limited to society and hospitals but is now spreading into the wild. Escalating resistance to antibiotics over the last few years has crystallized into one of the greatest threats to well-functioning health care in the future." Uppsala University |
|||||||||||||||||||||
| Related Antibiotics Current Events and Antibiotics News Articles A Second Skin Despite advances in treatment regimens and the best efforts of nurses and doctors, about 70% of all people with severe burns die from related infections. Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. New imagining technique could lead to better antibiotics and cancer drugs A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Henry Ford Hospital study: A MRSA strain linked to high death rates A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study. Bacteria 'launch a shield' to resist attack Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system. Pumpkin skin may scare away germs The skin of that pumpkin you carve into a Jack-o'-Lantern to scare away ghosts and goblins on Halloween contains a substance that could put a scare into microbes that cause millions of cases of yeast infections in adults and infants each year. Deadly stomach infection rising in community settings, Mayo Clinic study finds Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings. New clinical guidelines for exacerbations in cystic fibrosis The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices. More Antibiotics Current Events and Antibiotics News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||